Back to Search Start Over

Insulin-regulated aminopeptidase immunoreactivity is abundantly present in human hypothalamus and posterior pituitary gland, with reduced expression in paraventricular and suprachiasmatic neurons in chronic schizophrenia.

Authors :
Bernstein, Hans-Gert
Müller, Susan
Dobrowolny, Hendrik
Wolke, Carmen
Lendeckel, Uwe
Bukowska, Alicja
Keilhoff, Gerburg
Becker, Axel
Trübner, Kurt
Steiner, Johann
Bogerts, Bernhard
Source :
European Archives of Psychiatry & Clinical Neuroscience. Aug2017, Vol. 267 Issue 5, p427-443. 17p. 3 Color Photographs, 7 Charts, 1 Graph.
Publication Year :
2017

Abstract

The vasopressin- and oxytocin-degrading enzyme insulin-regulated aminopeptidase (IRAP) is expressed in various organs including the brain. However, knowledge about its presence in human hypothalamus is fragmentary. Functionally, for a number of reasons (genetic linkage, hydrolysis of oxytocin and vasopressin, its role as angiotensin IV receptor in learning and memory and others) IRAP might play a role in schizophrenia. We studied the regional and cellular localization of IRAP in normal human brain with special emphasis on the hypothalamus and determined numerical densities of IRAP-expressing cells in the paraventricular, supraoptic and suprachiasmatic nuclei in schizophrenia patients and controls. By using immunohistochemistry and Western blot analysis, IRAP was immunolocalized in postmortem human brains. Cell countings were performed to estimate numbers and numerical densities of IRAP immunoreactive hypothalamic neurons in schizophrenia patients and control cases. Shape, size and regional distribution of IRAP-expressing cells, as well the lack of co-localization with the glia marker glutamine synthetase, show that IRAP is expressed in neurons. IRAP immunoreactive cells were observed in the hippocampal formation, cerebral cortex, thalamus, amygdala and, abundantly, hypothalamus. Double labeling experiments (IRAP and oxytocin/neurophysin 1, IRAP with vasopressin/neurophysin 2) revealed that IRAP is present in oxytocinergic and in vasopressinergic neurons. In schizophrenia patients, the numerical density of IRAP-expressing neurons in the paraventricular and the suprachiasmatic nuclei is significantly reduced, which might be associated with the reduction in neurophysin-containing neurons in these nuclei in schizophrenia. The pathophysiological role of lowered hypothalamic IRAP expression in schizophrenia remains to be established. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09401334
Volume :
267
Issue :
5
Database :
Academic Search Index
Journal :
European Archives of Psychiatry & Clinical Neuroscience
Publication Type :
Academic Journal
Accession number :
124090347
Full Text :
https://doi.org/10.1007/s00406-016-0757-7